Welcome Back
Click “Sign in” to agree to Cointime’s Terms of Service and acknowledge that Cointime’s Privacy Policy applies to you.
Join CoinTime
Already have an account?
Click “page.Sign up” to agree to Cointime’s <a class="underline" href="#term-of-service">Terms of Service</a> and acknowledge that Cointime’s a class="underline" href="#privacy-policy">Privacy Policy</a> applies to you.
Sign in with email
Sign up with email
Your email
Check your inbox
Click the link we sent to to sign in.
Click the link we sent to to sign up.
Antiverse
company
About
Antiverse is dedicated to engineering the future of drug development to change the course of people's lives.
- 1 - 10
Highlights
Details
- Last Funding Type
- Grant
- Last Funding Money Raised
- £20K
- Industries
- Artificial Intelligence,Biotechnology,Health Care,Life Science,Machine Learning
- Founded date
- Apr 1, 2017
- Number Of Employee
- 1 - 10
- Operating Status
- Active
Antiverse is a new type of antibody discovery company accelerating drug development. Its platform exists at the intersection of structural biology, machine learning, and medicine to enable breakthroughs to happen more quickly and cost-effectively. It is dedicated to engineering the future of drug development to change the course of people's lives.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
1
£20K
Antiverse has raised a total of
£20K
in funding over 2 rounds. Their latest funding was raised on
Jul 12, 2018 from a Grant round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Jul 12, 2018 | Grant | £20K | 1 |
Accelerate@Babraham
|
— | Detail |
Investors
Number of Lead Investors
Number of Investors
1
1
Antiverse is funded by 1 investors.
Accelerate@Babraham
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
|
Accelerate@Babraham
|
Yes | Grant |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
